Edralbrutinib [1858206-58-2]

TargetMol Chemicals

Edralbrutinib [1858206-58-2]

9

1858206-58-2

Chemical

Research Use Only

Edralbrutinib

99.47%

C26H21F2N5O3

489.47

Edralbrutinib (TG-1701) is a potent BTK inhibitor with anticancer activity used in treating tumors, immune system disorders, and blood and lymphatic system disorders. Additionally, Edralbrutinib is studied for its efficacy in membranous glomerulonephritis and optic neuromyelitis optica.

3 years

O=C1C2=C(C(=CN2[C@H]3CN(C(C#CC)=O)CC3)C4=CC=C(OC5=C(F)C=CC=C5F)C=C4)C(N)=NN1

-20°C

12352200